Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Yueqing Xie"'
Autor:
Jiawei Zhang, Junjun Liu, Yali Yue, Lei Wang, Qunye He, Shuyi Xu, Junyan Li, Yunji Liao, Yu Chen, Shusheng Wang, Yueqing Xie, Baohong Zhang, Yanlin Bian, Dimiter S. Dimitrov, Yunsheng Yuan, Jianwei Zhu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract Background Though tamoxifen achieves success in treating estrogen receptor α (ERα)-positive breast cancer, the followed development of tamoxifen resistance is a common challenge in clinic. Signals downstream of prolactin receptor (PRLR) co
Externí odkaz:
https://doaj.org/article/c25ae8cc70c544b79719f5ae53eeff5a
Autor:
Jingjing Wang, Yueqing Xie, Ting Wu, Yichun Chen, Mingzhen Jiang, Xuhai Li, Yingrong Ye, Ershun Zhou, Zhengtao Yang
Publikováno v:
Poultry Science, Vol 103, Iss 9, Pp 104027- (2024)
ABSTRACT: Phytic acid (PA) is a natural antioxidant with various biological activities, providing protective effects in multiple animals. Ochratoxin A (OTA) is a mold toxin commonly found in feed, which induces multi-organ damage, with kidney being t
Externí odkaz:
https://doaj.org/article/efe6f282081442f7bd9a202f74cd3a1b
Autor:
Shusheng Wang, Yunji Liao, Kaiyong Yang, Hang Ma, Zhangyi Song, Haiqiu Huang, Li Zhang, Ailing Wang, Lei Han, Jiawei Zhang, Hui Chen, Haiyang Yin, Yanlin Bian, Hua Jiang, Xiaodong Xiao, Yueqing Xie, Yunsheng Yuan, Jianwei Zhu
Publikováno v:
Genes and Diseases, Vol 11, Iss 4, Pp 101088- (2024)
Externí odkaz:
https://doaj.org/article/bb6b47f7d6ff48c787260491b58f9d0d
Autor:
Yuan Yuan, Junyan Li, Jie Chen, Lei Han, Lei Wang, Yali Yue, Junjun Liu, Baohong Zhang, Yunsheng Yuan, Mingyuan Wu, Yanlin Bian, Yueqing Xie, Jianwei Zhu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 174, Iss , Pp 116565- (2024)
Neural cell adhesion molecule L1 (L1CAM) is a cell-surface glycoprotein involved in cancer occurrence and migration. Up to today, L1CAM-targeted therapy appeared limited efficacy in clinical trials although quite a few attempts by monoclonal antibody
Externí odkaz:
https://doaj.org/article/3aa3ee8a89054e06815fdcd7be5e3748
Publikováno v:
地质科技通报, Vol 42, Iss 3, Pp 262-271 (2023)
Groundwater pollution risk assessment is an effective tool for preventing and controlling groundwater pollution. The study on groundwater pollution risk assessment can serve as a basis for the management of groundwater contaminated sites. The present
Externí odkaz:
https://doaj.org/article/e190c56c033b48199a9c390bd2b51691
Publikováno v:
Shuiwen dizhi gongcheng dizhi, Vol 50, Iss 2, Pp 160-170 (2023)
Contaminants in groundwater can spread downstream, causing risks to receptors along the path. The risk assessment of our current site groundwater contamination focuses mainly on human health risks. It rarely considers integrated risks of groundwater
Externí odkaz:
https://doaj.org/article/f45ff69e5e064e3dbe0c103b10a6b267
Autor:
Shuai Hao, Shuyi Xu, Liangzhu Li, Yaxian Li, Meiqi Zhao, Junsheng Chen, Shunying Zhu, Yueqing Xie, Hua Jiang, Jianwei Zhu, Mingyuan Wu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background: Antibodies and derivative drugs targeting immune checkpoints have been approved for the treatment of several malignancies, but there are fewer responses in patients with pancreatic cancer. Here, we designed a nanobody molecule wi
Externí odkaz:
https://doaj.org/article/3e00bfdc6861413c8cde585309b0cf39
Autor:
Jie Chen, Zhidi Pan, Lei Han, Junjun Liu, Yali Yue, Xiaodong Xiao, Baohong Zhang, Mingyuan Wu, Yunsheng Yuan, Yanlin Bian, Hua Jiang, Yueqing Xie, Jianwei Zhu
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e17960- (2023)
CD22, as the B-cell malignancies antigen, has been targeted for immunotherapies through CAR-T cells, antibody-drug conjugates (ADCs) and immunotoxins via interaction of antibodies with binding domains on the receptor. We hypothesized that avidity and
Externí odkaz:
https://doaj.org/article/8a9efbab6c0e4e788c7d1533d5c245c1
Autor:
Zhidi Pan, Jie Chen, Xiaodong Xiao, Yueqing Xie, Hua Jiang, Baohong Zhang, Huili Lu, Yunsheng Yuan, Lei Han, Yuexian Zhou, Huifang Zong, Lei Wang, Rui Sun, Jianwei Zhu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 4, Pp 1928-1942 (2022)
T cell engaging bispecific antibody (TCB) is an effective immunotherapy for cancer treatment. Through co-targeting CD3 and tumor-associated antigen (TAA), TCB can redirect CD3+ T cells to eliminate tumor cells regardless of the specificity of T cell
Externí odkaz:
https://doaj.org/article/0db153f735884cd9a2537533cb0d467b
Autor:
Hang Ma, Yingying Guo, Haoneng Tang, Chien-Te K. Tseng, Lei Wang, Huifang Zong, Zhenyu Wang, Yang He, Yunsong Chang, Shusheng Wang, Haiqiu Huang, Yong Ke, Yunsheng Yuan, Mingyuan Wu, Yuanyuan Zhang, Aleksandra Drelich, Kempaiah Rayavara Kempaiah, Bi-Hung Peng, Ailin Wang, Kaiyong Yang, Haiyang Yin, Junjun Liu, Yali Yue, Wenbo Xu, Shuangli Zhu, Tianjiao Ji, Xiaoju Zhang, Ziqi Wang, Gang Li, Guangchun Liu, Jingjing Song, Lingling Mu, ZongShang Xiang, Zhangyi Song, Hua Chen, Yanlin Bian, Baohong Zhang, Hui Chen, Jiawei Zhang, Yunji Liao, Li Zhang, Li Yang, Yi Chen, John Gilly, Xiaodong Xiao, Lei Han, Hua Jiang, Yueqing Xie, Qiang Zhou, Jianwei Zhu
Publikováno v:
Cell Discovery, Vol 8, Iss 1, Pp 1-14 (2022)
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) continue to wreak havoc across the globe. Higher transmissibility and immunologic resistance of VOCs bring unprecedented challenges to epidemic extinguis
Externí odkaz:
https://doaj.org/article/af5efd28aaa94c95aeff30464ad22437